Literature DB >> 21352846

Long-term methadone treatment impairs novelty preference in rats both when present and absent in brain tissue.

Jannike M Andersen1, Christine F Olaussen, Ase Ripel, Jørg Mørland.   

Abstract

Behavioral consequences of long-term methadone treatment have received little attention either in humans or experimental animals. In this work, we show that methadone (2.5-10 mg/kg) administered (sc) once daily for three weeks with repeated withdrawal on Saturday and Sunday impairs the novelty preference in rats. One hour after the last injection, when methadone was still present in brain tissue, the rats were too affected by the sedative effects of the drug to perform the test. This was confirmed by an almost total lack of locomotor activity or exploratory behavior. One day after the last injection, the methadone treated rats showed a 70% reduction (p < 0.05) in novelty preference compared to rats administered saline. No methadone was detected in the brain tissue at this time. Moreover, there were no differences in locomotor activity or total exploratory behavior between the groups, indicating a specific impairment of cognitive functioning. In brain tissue, the methadone concentration versus time profile was shifted to the left after long-term treatment, indicating a change in uptake and distribution of the drug. The area under the two concentration versus time curves was, however, similar. Methadone disappeared completely from the brain within one day. Together, these results suggest that long-term methadone treatment may have a negative impact on cognitive functioning in rats, regardless of whether methadone is present in brain tissue.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21352846     DOI: 10.1016/j.pbb.2011.02.017

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  6 in total

1.  Longitudinal behavioral and fMRI-based assessment of inhibitory control in heroin addicts on methadone maintenance treatment.

Authors:  Jian-Jun Ye; Wei Li; Dong-Sheng Zhang; Qiang Li; Jia Zhu; Jia-Jie Chen; Yong-Bin Li; Xue-Jiao Yan; Jie-Rong Liu; Xuan Wei; Ya-Rong Wang; Wei Wang
Journal:  Exp Ther Med       Date:  2018-08-03       Impact factor: 2.447

2.  A Mixed-Method Analysis of Persisting Effects Associated with Positive Outcomes Following Ibogaine Detoxification.

Authors:  Alan K Davis; Elise Renn; Austin-Marley Windham-Herman; Martin Polanco; Joseph P Barsuglia
Journal:  J Psychoactive Drugs       Date:  2018-07-18

3.  Comparing the effects of methadone maintenance treatment, therapeutic community, and residential rehabilitation on quality of life and mental health of drug addicts.

Authors:  Ensiyeh Babaie; Nader Razeghi
Journal:  Addict Health       Date:  2013 Winter-Spring

4.  Subjective effectiveness of ibogaine treatment for problematic opioid consumption: Short- and long-term outcomes and current psychological functioning.

Authors:  Alan K Davis; Joseph P Barsuglia; Austin-Marley Windham-Herman; Marta Lynch; Martin Polanco
Journal:  J Psychedelic Stud       Date:  2017-10-17

5.  Delay-Dependent Impairments in Memory and Motor Functions After Acute Methadone Overdose in Rats.

Authors:  Leila Ahmad-Molaei; Hossein Hassanian-Moghaddam; Fariba Farnaghi; Carlos Tomaz; Abbas Haghparast
Journal:  Front Pharmacol       Date:  2018-09-10       Impact factor: 5.810

6.  The Protective and Restorative Effects of Growth Hormone and Insulin-Like Growth Factor-1 on Methadone-Induced Toxicity In Vitro.

Authors:  Erik Nylander; Sofia Zelleroth; Fred Nyberg; Alfhild Grönbladh; Mathias Hallberg
Journal:  Int J Mol Sci       Date:  2018-11-17       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.